Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01407341 · ClinicalTrials.gov registry record · Phase 1
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
A Phase 1 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01407341 is a Phase 1 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 1 participants.
The verdict
NCT01407341, a Phase 1 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This pilot clinical trial studies beta-tricalcium phosphate bone graft in treating patients undergoing surgery for metastatic spine cancer. A bone graft may help healing and bone growth in patients undergoing surgery for spine cancer
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- PROCEDURE musculoskeletal complications management/prevention
- PROCEDURE bone graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01407341
The ClinicalTrials.gov registry entry for NCT01407341 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which questionnaire administration is the first listed.
NCT01407341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01407341 about?
NCT01407341 is a clinical study titled "Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer". This pilot clinical trial studies beta-tricalcium phosphate bone graft in treating patients undergoing surgery for metastatic spine cancer. A bone graft may help healing and bone growth in patients undergoing surgery for spine cancer
What is the current status of trial NCT01407341?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2011-06. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01407341?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), musculoskeletal complications management/prevention (PROCEDURE), bone graft (PROCEDURE).
Who is sponsoring clinical trial NCT01407341?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.